Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC25H27N5O3S |
InChIKeyJAHXQCZCZURPTI-UHFFFAOYSA-N |
CAS Registry1338793-07-9 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Neoplasms | Preclinical | Canada | 01 Sep 2014 |





